Phase 4 Hepatitis B Clinical Trials
15 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–15 of 15 trials
Recruiting
Phase 4
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Chronic Hepatitis B
Chinese University of Hong Kong412 enrolled1 locationNCT06364930
Recruiting
Phase 4
National Liver Cancer Screening Trial
Liver CancerCarcinoma, HepatocellularLiver Cirrhosis+1 more
University of Texas Southwestern Medical Center5,500 enrolled18 locationsNCT06084234
Recruiting
Phase 4
Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Hepatitis B Virus (HBV)Lung Transplant Recipient
University Health Network, Toronto20 enrolled1 locationNCT07189377
Recruiting
Phase 4
Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients
Hepatitis B, Chronic
Third Affiliated Hospital, Sun Yat-Sen University5,000 enrolled1 locationNCT05182463
Recruiting
Phase 4
Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK)
Chronic Hepatitis B
Humanity & Health Medical Group Limited2,000 enrolled1 locationNCT03792919
Recruiting
Phase 4
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
Hepatitis B
Rockefeller University12 enrolled1 locationNCT05272735
Recruiting
Phase 4
Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B
Hepatitis BViral Hepatitis
Taichung Veterans General Hospital140 enrolled1 locationNCT03933384
Recruiting
Phase 4
Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis
Hepatitis BCirrhosis, LiverChronic Liver Disease
Mercy Medical Center200 enrolled1 locationNCT04588077
Completed
Phase 4
Tenofovir Alafenamide (TAF) Breast Milk Pharmacokinetics (PK) study
hepatitis B infection
South Western Sydney Local Health District10 enrolled2 locationsACTRN12619000419167
Active
Phase 4
A randomized controlled trial to study whether telbivudine can prevent virus reactivation and improve the prognosis after liver resection in patients with hepatitis B virus-related hepatocellular carcinoma
hepatitis B virus-related hepatocellulcar carcinoma
ZHOU Wei-ping200 enrolled1 locationACTRN12614001224617
Recruiting
Phase 4
Asses the safety and efficacy of switching to tenofovir and lamivudine therapy in patients who have been receiving Hepatitis B Immunoglobulin and lamivudine prophylasix post liver transplant.
prevent Hepatitis B virus re-infection following liver transplantation with the use of tenofovir and lamivudine, withdrawing HBIG.
Professor Peter Angus40 enrolled1 locationACTRN12611001236987
Recruiting
Phase 4
The Evaluation of efficacy and safety of Tenofovir in combination with peginterferon alpha-2a subcutaneous for 48 weeks in patients with chronic hepatitis B viral infections (HBV)
Chronic Hepatitis B viral infection
Dr Anouk Dev75 enrolled1 locationACTRN12610001101077
Completed
Phase 4
Intramuscular and intradermal hepatitis B vaccine administration: immunological response in hemodialysis patients
Hepatitis B vaccinationHemodialysis
Nefrologia – Faculdade de Medicina/Instituto de Pesquisas Biomedicas/Hospital Sao Lucas from PUCRS198 enrolled1 locationACTRN12609000616279
Recruiting
Phase 4
The Extension Study
Chronic Hepatitis B Virus Infection
Prof. Meng Ngu, Concord Hospital28 enrolled1 locationACTRN12606000283572
Completed
Phase 3Phase 4
Virological and clinical anti-HBV efficacy of tenofovir in antiretroviral naive patients with HIV/HBV co-infection
HIV Hepatitis B Coinfection
National Centre in HIV Epidemiology and Clincial Research51 enrolled1 locationACTRN12605000436673